Ancilia has unparalleled ability to identify and functionally characterize viruses

Our proprietary computational platform leverages CRISPR to map viral-bacterial interactions

CRISPR’s natural immune function can then be harnessed to develop a new class of bacterial products with immunity against viruses – to enable a range of therapeutic, industrial and agritech applications